研究開発

<代表論文>

1. Taguchi I et al High-dose versus low-dose Pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD) A randomized superiority trial Circulation 2018;137:1997-2009
2. Ikeda Y et al Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors JAMA 2014;312:2510-20
3. Kohro T et al Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients Circ J 2011;75:2062-70
4. Yamazaki T et al Prevalence awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan Results from domestic baseline data of the REduction of Atherothrombosis for Continued Health (REACH) Registry Circ J 2007;71:995-1003
5. Yamazaki T et al Current status of the background of patients with coronary artery disease in Japan: The Japanese Coronary Artery Disease Study (The JCAD Study) Circ J 2006;70:1256-62

<researchmap>

https://researchmap.jp/02fujita

<代表論文>

1. Fujita R, Kurosu H, Norizuki M, Ohishi T, Zamoto-Niikura A, Iwaki M, Mochida K, Takagi H, Harada T, Tsushima K, Matsumoto T, Hanaki KI, Sugai M, Yamagishi T. Potential risk of SARS-CoV-2 infection among people handling linens used by COVID-19 patients before and after washing. Sci Rep. 2022 Sep2;12(1):14994.
2. Fujita R, Arbogast JW, Yoshida R, Hori S. A multi-centre study of the effects of direct observation of hand hygiene practices on alcohol-based handrub consumption. Infect Prev Pract. 2022 Oct 20;4(4):100256.
3. Tamura M, Fujita R, Sato T, Sato R, Kato Y, Nagasawa M, Matsumoto T. Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workers. J Infect Chemother. 2022 Nov;28(11):1478-1482.
4. Terada J, Fujita R, Kawahara T, Hirasawa Y, Kinoshita T, Takeshita Y, Isaka Y, Kinouchi T, Tajima H, Tada Y, Tsushima K. Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open-label, single-center phase 3 randomized clinical trial. EClinicalMedicine. 2022 Jul;49:101484.
5. Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R. High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial. Circulation. 2018 May 8;137(19):1997-2009.
6. Kinoshita D, Hada S, Fujita R, Matsunaga N, Sakaki H, Ohki Y. Maximal sterile barrier precautions independently contribute to decreased central line-associated bloodstream infection in very low birth weight infants: A prospective multicenter observational study. Am J Infect Control. 2019 Nov;47(11):1365-1369.
7. Fujita R, Iimuro S, Shinozaki T, Sakamaki K, Uemura Y, Takeuchi A, Matsuyama Y, Ohashi Y. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. Am J Infect Control. 2013 Dec;41(12):1231-5.
8. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T, Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada K, Fujita R, Saito H, Okinaka K, Griffith M, Parry AE, Barnetson B, Leonard J, Wakita T. Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship. J Infect Dis. 2020 Sep 1;222(7):1098-1102.

<代表論文>

1. 経時測定バイオマーカーを用いた生存時間アウトカムに対する動的予測―ジョイントモデルとランドマークアプローチ―, 計量生物学, Vol. 45, No. 2, 57–82 (2024)